Chemo-genomic interrogation of CEBPA mutated AML reveals recurrent CSF3R mutations and subgroup sensitivity to JAK inhibitors
V. P. Lavallee,
J. Krosl,
S. Lemieux,
G. Boucher,
P. Gendron,
C. Pabst,
I. Boivin,
A. Marinier,
C. J. Guidos,
S. Meloche,
J. Hebert,
G. Sauvageau
2016